HUINNO AIM
Latest round
- Seed
Last raised
- Aug 2022
Total raised
- $3M
Investors
- 4
About HUINNO AIM
Based in South Korea, and founded in 2022, HUINNO AIM operates as a HealthTech (healthcare technology) company., FuturePlay, and AON Investment. As of 2022, the company’s CEO is Young-Jun Gil. HUINNO AIM offers (artificial intelligence) AI-based CDSS (clinical decision support system), which is a device that helps in the clinical diagnosis and predicts a wide range of diseases. The company's AI technology gathers and analyzes biosignals including oxygen saturation (SpO2), respiration (RR), and body temperature (BT) to assist hospitals and medical staff in making better clinical diagnosis judgments.
Who invested in HUINNO AIM
4 investors across 1 round
See all investors in HUINNO AIM
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 17, 2022
Amount
$3M
Investors
Questions about HUINNO AIM
Who invested in HUINNO AIM?
HUINNO AIM has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HUINNO AIM raised?
HUINNO AIM has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did HUINNO AIM last raise money?
HUINNO AIM's most recent round on record is a Seed, in Aug 2022.
What does HUINNO AIM do?
Based in South Korea, and founded in 2022, HUINNO AIM operates as a HealthTech (healthcare technology) company.
Where is HUINNO AIM headquartered?
HUINNO AIM is headquartered in Seoul, South Korea.
Which VCs invest in companies like HUINNO AIM?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back medical devices & equipment companies at HUINNO AIM's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like HUINNO AIM? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.